Bissette G - Search Results

1

Cerebrospinal fluid thyrotropin-releasing hormone concentrations in patients with anxiety disorders.

Fossey MD, Lydiard RB, Ballenger JC, Laraia MT, Bissette G, Nemeroff CB. Fossey MD, et al. Among authors: bissette g. J Neuropsychiatry Clin Neurosci. 1993 Summer;5(3):335-7. doi: 10.1176/jnp.5.3.335. J Neuropsychiatry Clin Neurosci. 1993. PMID: 8369645

2

CSF corticotropin releasing hormone, somatostatin, and thyrotropin releasing hormone in schizophrenia.

Banki CM, Karmacsi L, Bissette G, Nemeroff CB. Banki CM, et al. Among authors: bissette g. Psychiatry Res. 1992 Jul;43(1):13-21. doi: 10.1016/0165-1781(92)90137-r. Psychiatry Res. 1992. PMID: 1359593

3

Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, beta-endorphin and somatostatin.

Nemeroff CB, Bissette G, Akil H, Fink M. Nemeroff CB, et al. Among authors: bissette g. Br J Psychiatry. 1991 Jan;158:59-63. doi: 10.1192/bjp.158.1.59. Br J Psychiatry. 1991. PMID: 1673078

4

Neurotensin-like immunoreactivity in cerebrospinal fluid of patients with schizophrenia, depression, anorexia nervosa-bulimia, and premenstrual syndrome.

Nemeroff CB, Bissette G, Widerlov E, Beckmann H, Gerner R, Manberg PJ, Lindstrom L, Prange AJ Jr, Gattaz WF. Nemeroff CB, et al. Among authors: bissette g. J Neuropsychiatry Clin Neurosci. 1989 Winter;1(1):16-20. doi: 10.1176/jnp.1.1.16. J Neuropsychiatry Clin Neurosci. 1989. PMID: 2577718

5

Cerebrospinal fluid somatostatin concentrations in schizophrenia and schizoaffective disorder: the effects of antipsychotic treatment.

Sharma RP, Bissette G, Janicak P, Davis JM, Nemeroff CB. Sharma RP, et al. Among authors: bissette g. Schizophr Res. 1994 Sep;13(2):173-7. doi: 10.1016/0920-9964(94)90099-x. Schizophr Res. 1994. PMID: 7986775

6

Cerebrospinal fluid corticotropin-releasing factor concentrations in patients with anxiety disorders and normal comparison subjects.

Fossey MD, Lydiard RB, Ballenger JC, Laraia MT, Bissette G, Nemeroff CB. Fossey MD, et al. Among authors: bissette g. Biol Psychiatry. 1996 Apr 15;39(8):703-7. doi: 10.1016/0006-3223(95)00197-2. Biol Psychiatry. 1996. PMID: 8731457 Clinical Trial.

7

Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and diazepam-binding inhibitor (DBI) during alcohol withdrawal and abstinence.

Adinoff B, Anton R, Linnoila M, Guidotti A, Nemeroff CB, Bissette G. Adinoff B, et al. Among authors: bissette g. Neuropsychopharmacology. 1996 Sep;15(3):288-95. doi: 10.1016/0893-133X(95)00212-V. Neuropsychopharmacology. 1996. PMID: 8873112

8

Cerebrospinal fluid corticotropin-releasing factor increases following haloperidol withdrawal in chronic schizophrenia.

Forman SD, Bissette G, Yao J, Nemeroff CB, van Kammen DP. Forman SD, et al. Among authors: bissette g. Schizophr Res. 1994 Apr;12(1):43-51. doi: 10.1016/0920-9964(94)90083-3. Schizophr Res. 1994. PMID: 8018584 Clinical Trial.

9

Alterations in cerebrospinal fluid concentrations of somatostatin-like immunoreactivity in chronic pain patients.

Urban BJ, France RD, Bissette G, Spielman FJ, Nemeroff CB. Urban BJ, et al. Among authors: bissette g. Pain. 1988 May;33(2):169-172. doi: 10.1016/0304-3959(88)90087-5. Pain. 1988. PMID: 2967947

10

Cerebrospinal fluid neuropeptides in mood disorder and dementia.

Banki CM, Karmacsi L, Bissette G, Nemeroff CB. Banki CM, et al. Among authors: bissette g. J Affect Disord. 1992 May;25(1):39-45. doi: 10.1016/0165-0327(92)90091-j. J Affect Disord. 1992. PMID: 1352520

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters